Evidence map›Paper›PMID 23377902›Full record

ArticlePhotosynthesis research2013

Re-evaluation of the side effects of cytochrome b6f inhibitor dibromothymoquinone on photosystem II excitation and electron transfer.

Ahmed Belatik, David Joly, Surat Hotchandani, Robert Carpentier

Abstract read
PubMed Publisher
In one paragraph

Article in Photosynthesis research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ahmed BelatikGroupe de Recherche en Biologie Végétale, Département de Chimie-Biologie, Université du Québec à Trois-Rivières, C.P. 500, Trois-Rivières, QC, G9A 5H7, Canada.
David Joly
Surat Hotchandani
Robert Carpentier
Université du Québec à Trois-Rivières · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dibromothymoquinone (DBMIB) has been used as a specific inhibitor of plastoquinol oxidation at the Q0 binding site of the cytochrome b6f complex for 40 years. It is thought to suppress electron transfer between photosystem (PS) II and I, as well as cyclic electron transfer around PSI. However, DBMIB has also been reported to act as a quencher of chlorophyll excited states. In this study, we have re-evaluated the effects of DBMIB on chlorophyll excited states and PSII photochemistry. The results show that DBMIB significantly quenches the chlorophyll excited states of PSII antenna even at low concentration (from 0.1 μM), lowering the effective excitation rate of the actinic light. It also acts as a potent PSII electron acceptor retarding the reduction of the plastoquinone pool with almost maximal potency at 2 μM. Altogether, these results suggest that experiments using DBMIB can easily be misinterpreted and stress on the importance of taking into account all these side effects that occur in the same range of DBMIB concentration used for inhibition of plastoquinol oxidation (1 μM).

Indexed as

ChlorophyllChlorophyll ACytochrome b6f ComplexDibromothymoquinoneElectronsElectron TransportLuminescent MeasurementsMolecular Docking SimulationOxygenPhotosystem II Protein ComplexSpectrometry, FluorescenceSpectrum AnalysisSpinacia oleraceaTemperatureThylakoidsChlorophyllChlorophyll ACytochrome b6f ComplexDibromothymoquinoneOxygenPhotosystem II Protein Complex

Identifiers

PMID23377902
OpenAlexW2060561562

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.